Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuliana Mombelli

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Recent Patents on Cardiovascular Drug Discovery|May 25, 2013
Novel therapeutic strategies for the homozygous familial hypercholesterolemiaGiuliana Mombelli, Chiara Pavanello
Cardiovascular Therapeutics|May 20, 2008
Viability of developing CETP inhibitorsCesare R Sirtori, Giuliana Mombelli
Annals of Medicine|June 1, 2011
Clinical response to statins: mechanism(s) of variable activity and adverse effectsCesare R Sirtori, Giuliana Mombelli, Michela Triolo, et al.
International Journal of Cardiology|February 1, 2008
Persistently increased HDL-cholesterolemia and reduced triglyceridemia in a large lipid clinic population treated with fenofibrate for 15 years or longerGiuliana Mombelli, Francesca Banfi, Serena Falcioni, et al.
Metabolic Syndrome and Related Disorders|June 5, 2009
Waist-to-height ratio is a highly sensitive index for the metabolic syndrome in a Mediterranean populationGiuliana Mombelli, Anna M Zanaboni, Sabrina Gaito, et al.
Pharmacological Research|February 10, 2007
Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatinPiergiorgio Zuccaro, Giuliana Mombelli, Laura Calabresi, et al.
Current Vascular Pharmacology|January 28, 2017
Indicators of Cardiovascular Risk in Metabolic Syndrome: Long Term Follow-up in Italian PatientsGiuliana Mombelli, Chiara Pavanello, Samuela Castelnuovo, et al.
Journal of Clinical Lipidology|April 26, 2015
Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary preventionGiuliana Mombelli, Raffaella Bosisio, Laura Calabresi, et al.
Cardiovascular Therapeutics|March 27, 2010
Paradoxical decrease in high-density lipoprotein cholesterol with fenofibrate: a quite rare phenomenon indeedGiuliana Mombelli, Franco Pazzucconi, Alighiero Bondioli, et al.
Plos One|February 13, 2018
Influence of body variables in the development of metabolic syndrome-A long term follow-up studyChiara Pavanello, Anna Maria Zanaboni, Sabrina Gaito, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Recent Patents on Cardiovascular Drug Discovery|May 25, 2013
Novel therapeutic strategies for the homozygous familial hypercholesterolemiaGiuliana Mombelli, Chiara Pavanello
Cardiovascular Therapeutics|May 20, 2008
Viability of developing CETP inhibitorsCesare R Sirtori, Giuliana Mombelli
Annals of Medicine|June 1, 2011
Clinical response to statins: mechanism(s) of variable activity and adverse effectsCesare R Sirtori, Giuliana Mombelli, Michela Triolo, et al.
International Journal of Cardiology|February 1, 2008
Persistently increased HDL-cholesterolemia and reduced triglyceridemia in a large lipid clinic population treated with fenofibrate for 15 years or longerGiuliana Mombelli, Francesca Banfi, Serena Falcioni, et al.
Metabolic Syndrome and Related Disorders|June 5, 2009
Waist-to-height ratio is a highly sensitive index for the metabolic syndrome in a Mediterranean populationGiuliana Mombelli, Anna M Zanaboni, Sabrina Gaito, et al.
Pharmacological Research|February 10, 2007
Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatinPiergiorgio Zuccaro, Giuliana Mombelli, Laura Calabresi, et al.
Current Vascular Pharmacology|January 28, 2017
Indicators of Cardiovascular Risk in Metabolic Syndrome: Long Term Follow-up in Italian PatientsGiuliana Mombelli, Chiara Pavanello, Samuela Castelnuovo, et al.
Journal of Clinical Lipidology|April 26, 2015
Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary preventionGiuliana Mombelli, Raffaella Bosisio, Laura Calabresi, et al.
Cardiovascular Therapeutics|March 27, 2010
Paradoxical decrease in high-density lipoprotein cholesterol with fenofibrate: a quite rare phenomenon indeedGiuliana Mombelli, Franco Pazzucconi, Alighiero Bondioli, et al.
Plos One|February 13, 2018
Influence of body variables in the development of metabolic syndrome-A long term follow-up studyChiara Pavanello, Anna Maria Zanaboni, Sabrina Gaito, et al.
Pageof 3